Tracheobronchitis
12
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
A Multi-Center Diagnostic Stewardship Program to Improve Respiratory Culture Utilization in Critically Ill Children
Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR
Ventilator-associated Tracheobronchitis Initiative to Conduct Antibiotic Evaluation
Mechanical Insufflation-exsufflation and Hypertonic Saline in Nosocomial Bacterial Respiratory Tract Infection
Molecular vs Conventional Microbiologic Diagnosis for Infections in Lung Transplantation
Bronchoscopic Score for Prediction of Herpes Simplex-virus Type 1 (HSV-1) Reactivation
Effect of Chlorhexidine-Induced Oral Care on Ventilator-Related Some Respiratory System Complications
CT Scan and Lung Ultrasonography to Improve Diagnostic of Ventilation Acquired Pneumonia in ICU
Tracheobronchitis Prevention Trial
Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory Tract Infection
Antibiotic Treatment in Ventilator Associated Tracheobronchitis (VAT)
Aerosolized Antibiotics and Respiratory Tract Infection in Patients on Mechanical Ventilation